{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:32:09Z","timestamp":1770352329546,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.contraception.2005.09.015","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T07:14:39Z","timestamp":1133334879000},"page":"336-343","source":"Crossref","is-referenced-by-count":40,"title":["A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 \u03bcg ethinyl estradiol and a reference containing desogestrel and 30 \u03bcg ethinyl estradiol"],"prefix":"10.1016","volume":"73","author":[{"given":"Cornelis","family":"Kluft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Endrikat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Gerlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Heithecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.09.015_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.09.015_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multi-centered study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib4","first-page":"13","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity: a major breakthrough in tomorrow's oral contraception","volume":"3","author":"Foidart","year":"1995","journal-title":"Gynaecol Snapshot"},{"key":"10.1016\/j.contraception.2005.09.015_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib6","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progesterone, drospirenone, on the renin\u2013aldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2005.09.015_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","article-title":"Effect of an oral contraceptive containing drospirenone on the renin\u2013aldosterone system in healthy female volunteers","volume":"14","author":"Oelkers","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2005.09.015_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0010-7824(01)00236-0","volume":"64","author":"Endrikat","year":"2001","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.contraception.2005.09.015_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/ob.1998.v179.a92633","article-title":"Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review","volume":"179","author":"Winkler","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.09.015_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/0929867003374994","article-title":"Effects on haemostasis variables by second and third generation combined oral contraceptives: a review of directly comparative studies","volume":"7","author":"Kluft","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.contraception.2005.09.015_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2005.09.015_bib13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(99)80017-8","article-title":"Importance of levonorgestrel dose in oral contraceptives for effects on coagulation","volume":"354","author":"Kluft","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.09.015_bib14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Acquired APC resistance and oral contraceptives: a randomised cross-over study of two low dose oral contraceptives","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.09.015_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-7824(95)00271-5","article-title":"A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 \u03bcg and 30 \u03bcg ethinylestradiol","volume":"53","author":"Winkler","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1471-0528.1996.tb09716.x","article-title":"The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives","volume":"103","author":"Norris","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2005.09.015_bib19","first-page":"26","article-title":"A simple chromogenic assay for the determination of factor VII in microplates","volume":"54","author":"Oswaldsson","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0038-1646768","article-title":"Determination of human thrombin\u2013antithrombin III complex in plasma with an enzyme-linked immunosorbent assay","volume":"59","author":"Pelzer","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib21","series-title":"ECAT assay procedures. A manual of laboratory techniques","first-page":"77","article-title":"Antithrombin III activity and antigen","author":"Conard","year":"1992"},{"key":"10.1016\/j.contraception.2005.09.015_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0038-1646605","article-title":"Immunoreactivity of tissue plasminogen activator and its inhibitor complexes","volume":"61","author":"Ranby","year":"1989","journal-title":"Thromb Haemost"},{"issue":"Suppl 3","key":"10.1016\/j.contraception.2005.09.015_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0268-9499(92)90039-K","article-title":"Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods","volume":"6","author":"Meijer","year":"1992","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.contraception.2005.09.015_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/clinchem\/40.1.110","article-title":"Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated","volume":"40","author":"Meijer","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.contraception.2005.09.015_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1661109","article-title":"Evidence for the occurrence of a fast acting inhibitor of tissue-type plasminogen activation in human plasma","volume":"51","author":"Verheijen","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-7824(95)00271-5","article-title":"A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 \u03bcg and 30 \u03bcg ethinylestradiol","volume":"53","author":"Winkler","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/09513599609012318","article-title":"Ethinylestradiol 20 versus 30 \u03bcg combined with 150 \u03bcg desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system","volume":"10","author":"Winkler","year":"1996","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2005.09.015_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/09513599609045656","article-title":"Influence of two low-dose oral contraceptives containing ethinylestradiol (20 \u03bcg) and desogestrel or gestodene on carbohydrate metabolism during 1 year of use","volume":"10","author":"Gaspard","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2005.09.015_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13625189909040809","article-title":"A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 \u03bcg ethinylestradiol and either 2 mg chloramidine acetate or 150 \u03bcg desogestrel","volume":"4","author":"Winkler","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.09.015_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1613145","article-title":"Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test","volume":"88","author":"Curvers","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib31","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"Van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.09.015_bib32","first-page":"336","article-title":"Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production","volume":"85","author":"Brown","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2005.09.015_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00044-X","article-title":"An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables","volume":"59","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.015_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptives estrogen dose and the risk of deep venous thromboembolic disease","volume":"177","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2005.09.015_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/13625187.11661690.1996","article-title":"Oral contraceptives and venous thromboembolism: an epidemiological review","volume":"74","author":"Lidegaard","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.09.015_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09513599609041263","article-title":"Consensus development meeting 1995: combined oral contraceptives and cardiovascular disease. The Consensus Statement issued after the Second European Conference on Sex Steroids and Metabolism, Amsterdam, November 1995","volume":"10","author":"Writing Committee","year":"1996","journal-title":"Gynecol Endocrinol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T09:09:41Z","timestamp":1583917781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0010782405003951"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.09.015","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}